Pharmocann Global Temettü
Temettü kriter kontrolleri 0/6
Pharmocann Global does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
31.5%
Geri Alım Getirisi
Toplam Hissedar Getirisi | 31.5% |
Gelecekteki Temettü Verimi | n/a |
Temettü Büyümesi | n/a |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | n/a |
Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if PMCN-M's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if PMCN-M's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
Pharmocann Global Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (PMCN-M) | n/a |
Pazarın Alt %25'i (IL) | 2.4% |
Pazarın En İyi %25'i (IL) | 6.5% |
Sektör Ortalaması (Pharmaceuticals) | 1.8% |
Analist tahmini (PMCN-M) (3 yıla kadar) | n/a |
Önemli Temettü: Unable to evaluate PMCN-M's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate PMCN-M's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate PMCN-M's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as PMCN-M has not reported any payouts.